Toggle light / dark theme

Scientists revive activity in frozen mouse brains for the first time

A familiar trope in science fiction is the cryopreserved time traveller, their body deep-frozen in suspended animation, then thawed and reawakened in another decade or century with all of their mental and physical capabilities intact.

Researchers attempting the cryogenic freezing and thawing of brain tissue from humans and other animals — mostly young vertebrates — have already shown that neuronal tissue can survive freezing on a cellular level and, after thawing, a functional one to some extent. But it has not been possible to fully restore the processes necessary for proper brain functioning — neuronal firing, cell metabolism and brain plasticity.

A team in Germany has now demonstrated a method for cryopreserving and thawing mouse brains that leaves some of this functionality intact. The study, published on 3 March in Proceedings of the National Academy of Sciences 3, details the authors’ use of a method called vitrification, which preserves tissue in a glass-like state, along with a thawing process that preserves living tissue.

“If brain function is an emergent property of its physical structure, how can we recover it from complete shutdown?” asks Alexander German, a neurologist at the University of Erlangen–Nuremberg in Germany and lead author of the study. The findings, he says, hint at the potential to one day protect the brain during disease or in the wake of severe injury, set up organ banks and even achieve whole-body cryopreservation of mammals.

Mrityunjay Kothari, who studies mechanical engineering at the University of New Hampshire in Durham, agrees that the study advances the state of the art in cryopreservation of brain tissue. “This kind of progress is what gradually turns science fiction into scientific possibility,” he says. However, he adds that applications such as the long-term banking of large organs or mammals remain far beyond the capabilities of the study.

Article Featured in Nature.


Compact terahertz imaging system brings real-time, non-invasive clinical diagnostics closer

Scientists at the University of Warwick and University of Exeter have developed a fully fiber-coupled terahertz (THz) imaging system that significantly improves the speed, resolution, and clinical practicality of terahertz imaging. The study, published in Nature Communications, demonstrates a high-throughput, compact platform that overcomes key barriers limiting current THz systems—bringing real-time, non-invasive tissue imaging closer to routine clinical use.

“Terahertz imaging has shown immense promise for biomedical diagnostics, but its translation into real-world clinical tools has been hindered by bulky systems and slow acquisition speeds,” said Professor Emma MacPherson, Department of Physics, University of Warwick. “It’s an exciting breakthrough as the fiber coupling means that the system can be flexible and compact, meaning it can function as a handheld device or be integrated with a robot.”

Terahertz waves sit between microwaves and infrared light on the electromagnetic spectrum. Crucially, they are non-ionizing (meaning they do not carry the risks associated with X-rays) and are highly sensitive to water content, which helps reveal differences between healthy and diseased tissue. Despite this promise, most existing terahertz imaging systems are bulky and slow, limiting their use outside specialist labs.

Scientists Identified a Speech Trait That Foreshadows Cognitive Decline

Early signs of Alzheimer’s disease may be hidden in the way a person speaks, but it’s not yet clear which details of our diction are most critical for diagnosis.

A study from 2023 suggests that as we age, how we say something may matter more than what we say. Researchers at the University of Toronto think the pace of everyday speech may be a better indicator of cognitive decline than difficulty finding a word.

“Our results indicate that changes in general talking speed may reflect changes in the brain,” said cognitive neuroscientist Jed Meltzer when the research was published.

The Comb Jelly ‘Brain’ Is Far More Complex Than We Ever Realized

Comb jellies – very simple, gelatinous creatures best-known for their hypnotic underwater light shows – first appeared in Earth’s oceans around 550 million years ago.

For a long time, biologists have kind of considered them the living embodiment of ‘no thoughts, head empty’

But a new study suggests their central sensory organ is far more complex and brain-like than we realized.

New Experimental Drug Shrinks Tumors in Prostate Cancer Clinical Trial

A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a “masked T-cell engager”. This type of immunotherapy ignites our own immune arsenal to fight cancer.

In the trial, which is still in progress and has not yet undergone peer review, patients with advanced prostate cancer who had failed to respond to other treatments were given VIR-5500.

Remarkably, initial findings showed that in the patients who received the highest doses, 82% saw reductions in their PSA (prostate-specific antigen) levels – a commonly used measure of prostate cancer.

Hair-thin fiber-optic sensors could detect cancer by reading multiple biomarkers

Microscopic sensors that are as thin as a strand of hair but capable of taking multiple measurements simultaneously could revolutionize the diagnosis and monitoring of diseases like cancer. Researchers from Adelaide University’s Institute for Photonics and Advanced Sensing and the University of Stuttgart in Germany worked together to develop the tiny sensors using state-of-the-art, ultrafast 3D micro-printing technology.

The unique sensors target specific biomarkers and are printed directly onto the tip of optical fibers. They’re able to monitor several signals at the same time, including temperature and chemical changes. The paper is published in the journal Advanced Optical Materials.

“This breakthrough could lead to next-generation medical tools that track disease, guide treatment and monitor the body in real time,” said Associate Professor Shahraam Afshar, the project’s lead researcher from Adelaide University’s Institute for Photonics and Advanced Sensing.

Mitochondrial capsule transplantation therapy shows potential for major diseases

Chinese researchers have developed a novel and highly efficient mitochondrial capsule transplantation therapy, achieving the safe and efficient transplantation of healthy mitochondria into cells and tissues for the first time. This new therapy can significantly alleviate symptoms of severe diseases such as Parkinson’s disease.

According to the study, published in the journal Cell, the therapy proposes a brand-new strategy in the field of regenerative medicine, shedding fresh light on intervention in refractory diseases caused by mitochondrial dysfunction, such as mitochondrial genetic diseases and neuron degenerative disorders.

Mitochondria are organelles that refer to specialized subunits with specific functions in cells. Mitochondria function like power plants in cells, continuously converting nutrients into energy for life activities. They are also the only organelles in human cells that possess their own genome.

The function of mRNA quality control in aging and age-related diseases

Aging is a complex biological process characterized by the gradual decline of physiological and molecular functions and increased susceptibility to age-associated diseases. Emerging evidence indicates the role of mRNA quality control mechanisms in the regulation of aging and longevity. This review focuses on the function of mRNA surveillance mechanisms, including nonsense-mediated mRNA decay (NMD), nonstop decay (NSD), and no-go decay (NGD), in aging and age-related diseases. We discuss the critical roles of these pathways in maintaining mRNA quality and preventing the accumulation of aberrant transcripts, which can contribute to aging and age-related disorders.

Tissue and CD4 T cell subset dependence on the amino acid transporter SLC38A1

Metabolic demands and mechanisms of nutrient uptake shape T cell function and offer new therapeutic opportunities, but selective targeting remains challenging. Here, in vivo CRISPR screens show that CD4 T cell metabolism and nutrient uptake vary based on both cell subset and the tissue and inflammatory site.

/* */